Antiobiotics and Antimicrobial Reseistnace Flashcards

1
Q

whats the difference between antibiotics and antimicrobials?

A
  • *antibiotics:** natural antimicrobial substance - produced by living organism
  • *antimicrobial:** any substance that kills or inhibits growth of microbes

all antibiotics are antimicrobials, but not all antimicrobrials are antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is selective toxicity?

what can you target to achieve this?

A

selective toxicity: drug that kills or inhabits growth of pathogen without harming the host

  • *target:**
  • different essential vitamins that bacterial use
  • bacterial cell wall
  • bacteria rb (50S & 30S)
  • bacterial mt
  • DNA and RNA synthesis different
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

which are the current exploited antibiotic targets?

what are the most successful?

A
  • inhibition of bacterial cell wall synthesis
  • inhibition of bacterial protein synthesis
  • inhibition of DNA transcription and replication
  • inhibition of RNA synthesis and replication
  • *most successful hit:**
  • rb
  • cell wall synthesis
  • DNA gyrase or DNA toposiomerase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the classification of antibacterial agents? (2)

A

spectrum activity: broad spectrum: (target all) OR narrow spectrum: (e.g. only target gram positive or gram negative / or gram positive aerobes)

mode of action: bacteriostatic (stops it growing) or bactericidal (kils). in clinic can be both - depending on dose, duration of exposure or the state of invading bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

bacteriostatic or bactericidal e.g.s?

A

awareness probs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

which drugs target bacterial cell walls? how work?

explain how pencillin works

explain how glycopeptide antibiotics work

explain how polymyxins work

A

beta-lactam antiobiotics: inhibit cell wall synthesis
work: inhibit step in synthesis of peptidoglycan (most contain a B-lactam ring). causes cells to osmotically lyse

pencillin:
bacterial cell wall grows: get cross links between cell wall by pentaglycine (using enyzme transpeptidase)
penecillin acts as a mimic: as a substrate for transpeptidase. blocks it working

glycopeptide antibiotics:

  • too big to get through cell wall
  • block D-ala residues (D-ala form the cell wall cross links) from forming cross links by forming H-bonds between the D-ala
  • used on gram-positive bacteria

polymyxins:

  • bind to charge structures of cell walls on gram negative bacteria
  • changes the charge
  • this destabilises cell wall
  • rupture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how do antibacterial targeting protein synthesis work?
what do aminglycosides, tetracylines, macrolides and chloramphenicol do?

A

- aminglycosides: change shape of 30S portion & disrupt the structure (Gentamicin, tobramycin and amikacin). Gram-negative bacteria. can cause hearing loss and renal impairment. IV drugs

- tetracyclines: bind to 30S. interfere with attachment of tRNA to rb. oral drugs

- macrolides: bind to 50s subunit. prevents translocation

  • chloramphenicol: bind to 50S, inhibit formation of peptide bond
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

which drugs act on nucelic acid synthesis?

A

quinolones / fluoroquinolones:

  • broad spectrum
  • bind to topoisomerase II (DNA gyrase) and topoisomerase IV and inhibit DNA synthesis.

Rifampicin:

  • acts on RNA transcription: inhibits RNA polymerase on gram postive
  • treats TB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

which drugs target bacterial metabolic pathways

A

drugs target metabolic pathways unique to bacteria

  • *e.g. Sulphonamides and folic acid inhbitors: (e.g. trimethoprim and sulfamethoxazole)**
  • competitive inhibitors of bacterial synthesis of folic acid: block the bacterial precursor of FA - PABA by binding themselves, so FA cant be produced
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how do inactivated bacterial vaccines work?

what are the two types and what subtpyes?

A
  • *inactivated vaccines:**
  • chemical treatment of part of bacteria to make inactive: e.g. heat or purifcation of protein
  • large amount of antigen produces antibody repsonse
  • *inactiaved bacterial vaccines:
  • **whole bacteria killed
  • protein subunits inactivated
  • toxoid inactivated
  • *polysaccharide vaccines** (usually from cell wall):
  • pure poly.
  • conjugate vaccines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how do live bacterial vaccines work?

A
  • live attenuated (weakened) bacteria are grown over period of time
  • e.g. cholera
  • attenuated live bacteria will multiply more slowly than virulent strains
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is antimicrobial susceptibility testing? why do it?

A

= the measurement of the susceptibility of bacteria to antibiotics.

  • to see whether the therapy is likely to be effective
  • enable narow therapy to reduce AEs
  • allows data on resistance
  • enable antimicrob policies to be formed
  • provide surveillance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is minimal inhibitory concentration (MIC) of antiobiotic?

A

= minimal concentration of antibiotic required to inhbit the growth of organism

e.g. in picture: MIC = 0.03 mg/l

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are two methods of antimicrobial sus. testing?

A

broth microtitre dilution: often determined in 96-well microtiter plate format, bacteria are inoculated into a liquid growth medium in the presence of different concentrations of an antimicrobial agent. Growth is assessed after incubation for a defined period of time (16-20 h) and the MIC value is read. uses spectrophotometry

disc diffusion tests :An effective antibiotic will produce a large zone of inhibition (disk C), while an ineffective antibiotic may not affect bacterial growth at all (disk A).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what does susceptibility, intermediate and resistant mean?

what is a breakpoint??

A

susceptibility: bacterial strain inhibited in-vitro by a conc of an antimicrobial agent that is associated with a high likelihood of therapeutic success

intermediate: bacterial strain inhibited in-vitro by a conc of an antimicrobial agent that is associated with a uncertain therapeutic success

resistant: bacterial strain inhibited in-vitro by a conc of an antimicrobial agent that is associated with a high likelihood of therapeutic failure

breakpoint concentration: A breakpoint is a chosen concentration (mg/L) of an antibiotic which defines whether a species of bacteria is susceptible or resistant to the antibiotic. changes all the time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what do u do after done antimicrobial sus testing?

A

use a EUCAST Breakpoint tables: interpret test to indicate if microbe is susceptible or resistant

17
Q

what are PD indecies for antimicrobial activity and MIC?

A

effect of drug regarding its antimicrobial activity can differ regarding PD indices:

  • Cmax / MIC ratio - concentration depending killing: most importnat is getting high conc above MIC.
  • T>MIC - time dependent killing - most important is time above MIC. with minimal prolonged antibiotic effect
  • *- AUC24 / MIC ratio** - combo of above time dependent killing with prolonged antibiotic effect
18
Q

how long does antimicrobial resistance occur after drug introduced?

A
19
Q

what are two intrinsic mechanisms of resistance?

A
  1. gram-negative bacteria: outer membrane forms a permability barrier - drugs cannot cross
  2. efflux pumps: active transporter. Efflux systems function via an energy-dependent mechanism (active transport) to pump out unwanted toxic substances through specific efflux pumps.
20
Q
A
21
Q

what are 4 acquired antiobiotic resitance mechanisms

A
  • *1. drug inactivation**
  • *2. activation of drug pumps (pump out)**
  • *3. modification of target:** e.g. acquire new gene that methylates Rb, so is resistant to drugs that target Rb.
  • *4. alternative metabolic pathways**: e.g. with FA production, get mutations which mean that enzymes change structure so cant be targeted
22
Q

give an example of drug inactivation by B-lactamases

how get over this?

A

B-lactamases (aka penicillinase): Beta-lactamases are enzymes (EC 3.5. 2.6) produced by bacteria that provide multi- resistance to β-lactam antibiotics such as penicillins

  • beta-lactamase hydrolyse the b-lactam antibiotics and make it ineffective

beat this by: use inhibitors of b-lactamases.

23
Q

how does activation of efflux pumps work?

A

normally used to pump out metabolic waste:

  • undergo mutations - pump out drug instead
  • high level of resistance provided
  • *- genes for multidrug resistance efflux pumps integrate into plasmids can transfer between bacteria:** can be acquired or intrinsic
24
Q
A
25
Q

how does resistance spread between bacteria?

A

1.intrinsic / mutational resistance: clonal - mother to daughter cell
2. plasmid encoded resistance: clonal - mother to daughter cell
3. acquired resistance: plasmids / transposons / integrons: spread between clones and species

26
Q

what are high risk clones?

A
  • resistance of great clinical importance
    AND
  • high ability to spread in healthcare institutions
    OR
  • high ability to cause invasive disease
    OR
  • high ability to colonise humans for longer periods
27
Q
A
28
Q

what is plasmid addiction?

A
  • bacterial plasmid makes a toxin and an antidote - antitoxin
  • antitoxin degraded by intracellular enzymes
  • toxin is not degradeed
  • if daughter cell does not inherit the plasmid - cant synthesie the antitoxin = death
  • ensures that daughter cells carry the plasmid

plasmid addiction systems are now on the same plasmids as the resistance genes

29
Q

which bacteria have high priority antibacterial resistance?

A

the highly cirtical ones are all gram negative: have multi drug resistance. BUT THERE ARE NO NEW DRUGS IN THE PIPELNE :(

30
Q

what is solutions to AMR?

A
  • more effective prevention in antibiotic use
  • targeted treatments (limit use of broad spectrum antibiotics)
  • more informed clinical decisions
  • public education